The pharma robots market is poised for substantial growth, with a projected annual surge of 13.8% CAGR, catapulting its anticipated worth to an impressive US$ 683.4 million by the year 2032. This surge underscores the increasing integration of robotics in the pharmaceutical industry, where automation plays a pivotal role in enhancing efficiency, precision, and overall productivity. The escalating …